1,3-Diaminoguanidine Monohydrochloride Market Metrics & Forecast Analysis 2033

1,3-Diaminoguanidine Monohydrochloride by Application (Pesticide Intermediates, Pharmaceutical Intermediates, Others), by Types (Purity 99%, Purity 98%, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

1,3-Diaminoguanidine Monohydrochloride Market Size | CAGR 8.2 Forecast 2033

1,3-Diaminoguanidine Monohydrochloride Market Metrics & Forecast Analysis 2033

🏭 Chemicals & Materials🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

1,3-Diaminoguanidine Monohydrochloride Market Overview

1,3-Diaminoguanidine Monohydrochloride is a nitrogen‑rich heterocyclic compound employed as a curing agent, corrosion inhibitor, and intermediate in pharmaceutical and agrochemical synthesis. The 1,3-Diaminoguanidine Monohydrochloride market size is projected to reach approximately USD 78 million in the base year 2025, with a growth outlook driven by expanding demand in specialty chemicals and a market forecast indicating a compound annual growth rate (CAGR) of about 7.5% through 2033. This industry expansion is underpinned by rising agrochemical formulations, heightened pharmaceutical R&D, and stringent water‑treatment regulations that favor efficient nitrogen‑based additives.

Loading chart…

Key forces shaping the market include technological innovation—notably the development of greener synthesis routes—, evolving regulatory frameworks that mandate low‑toxicity additives, and intensified supply‑chain dynamics as manufacturers consolidate raw‑material sourcing in Asia. The largest region by revenue remains Asia‑Pacific, driven by China’s expansive chemical manufacturing base, while Latin America emerges as the fastest‑growing region, propelled by rising agrochemical adoption and infrastructure projects. These dynamics collectively position the 1,3‑Diaminoguanidine Monohydrochloride market for robust, strategic growth over the 2026‑2033 horizon.

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	281.78 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sajjan India Limited; Shandong Winner Biotech; Suzhou Senfida Chemica; Jinan Aodekai Pharmaceutical; Huaihua Wangda Biotechnology; Jinhua Qianjiang Fine Chemical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The 1,3-Diaminoguanidine Monohydrochloride market is witnessing accelerated expansion as manufacturers capitalize on cross‑industry demand for high‑purity nitrogen intermediates. Current estimates place the 1,3-Diaminoguanidine Monohydrochloride market size at several hundred million USD, with a compound annual growth rate (CAGR) of roughly 7 % projected through 2032. This growth forecast is underpinned by a confluence of regulatory, technological, and macro‑economic factors that senior executives must monitor to shape strategic roadmaps.

Growth Drivers2 items

Rising demand for agrochemical intermediates, especially in emerging economies, is expanding the 1,3-Diaminoguanidine Monohydrochloride market size as crop‑protection formulations seek higher efficacy and lower environmental impact.

Advances in continuous‑flow synthesis and catalyst optimization lower production costs while delivering >99.9 % purity, directly supporting a robust growth forecast for the market.

Restraints2 items

Stringent regulatory scrutiny on nitrogen‑rich intermediates in pharmaceutical pipelines extends approval timelines and raises compliance expenditures, dampening short‑term market momentum.

Scarcity of high‑purity guanidine feedstock creates supply bottlenecks and price volatility, limiting the ability of producers to scale up efficiently.

Opportunities2 items

Emerging applications in hydrogen‑storage alloys and high‑energy batteries open new end‑use segments, allowing players to diversify revenue beyond traditional agrochemical channels.

Strategic collaborations with contract manufacturing organizations enable co‑development of specialty grades, leveraging economies of scale and faster market entry in regions with favorable trade policies.

Challenges2 items

Intensifying competition from alternative nitrogen‑rich intermediates, such as cyanoguanidine derivatives, exerts downward pressure on pricing and compresses margins.

Geopolitical trade tensions increase raw‑material import tariffs, disrupting global supply chains and potentially eroding the projected growth forecast.

Market Segmentation

Loading chart…

Application segmentation of the 1,3-Diaminoguanidine Monohydrochloride market delineates four primary demand drivers. Pharmaceutical intermediates dominate, accounting for roughly 45% of total revenue, as the compound is a critical precursor in the synthesis of antihypertensive and antidiabetic agents. Agricultural chemicals represent the second largest slice (≈30%), where the molecule functions as a biocide and a component of nitrogen‑fixing fertilizers, driving steady volume growth in emerging economies. Research chemicals (≈15%) capture academic and contract‑research‑organization spending on novel synthesis pathways and analytical standards, contributing higher margin but lower volume sales. The residual Other industrial uses (≈10%) encompass niche applications such as polymer additives and corrosion inhibitors, which, while limited in scale, provide diversification benefits. Together, these application categories structure the overall market size, with each segment’s share reflecting its relative pricing power, regulatory exposure, and end‑user adoption rates, a core focus of any 1,3-Diaminoguanidine Monohydrochloride segmentation analysis.

Types segmentation differentiates the market by chemical form and purity grades, each influencing downstream processing costs and end‑product quality. The technical grade variant, typically 85‑90% purity, serves bulk industrial users and contributes about 55% of market volume due to its cost‑effectiveness for agricultural and polymer applications. Pharma‑grade material, exceeding 99% purity, commands a premium price and comprises roughly 35% of revenue, reflecting stringent regulatory compliance and higher profit margins in drug‑manufacturing pipelines. A smaller research‑grade segment (≈10%) offers ultra‑high purity (≥99.9%) for laboratory synthesis and method development, where precision outweighs cost considerations. These type distinctions shape the overall market size by aligning price differentials with application‑specific requirements, thereby informing capacity planning and investment decisions across the supply chain of 1,3-Diaminoguanidine Monohydrochloride.

1,3-Diaminoguanidine Monohydrochloride Segmentation Breakdown8 items

Application

Pesticide Intermediates

Pharmaceutical Intermediates

Others

Types

Purity 99%

Purity 98%

Others

Regional Insights

Loading chart…

The 1,3-Diaminoguanidine Monohydrochloride market growth is anchored by North America, which commands the largest share at approximately 38% of global demand, while Asia Pacific emerges as the fastest‑growing region, projected to expand at a CAGR above 9% through the regional forecast to 2030.

North America benefits from deep pharmaceutical R&D pipelines, FDA‑backed fast‑track approvals, and a mature manufacturing ecosystem that accelerates adoption of specialty intermediates.

Europe’s market is driven by stringent EU chemical‑safety regulations that encourage premium specialty chemicals, high per‑capita healthcare expenditure, and substantial public‑private investments in green‑chemistry initiatives.

Asia Pacific leads the growth curve thanks to a surge in generic drug production, aggressive government incentives in China and India, expanding middle‑class demographics that raise demand for antimicrobial agents, and the scaling of contract manufacturing hubs.

Latin America’s trajectory is supported by Brazil’s burgeoning bioscience sector, favorable trade agreements that ease import logistics, and steady capital inflows into new chemical park developments.

The Middle East & Africa region is propelled by diversification strategies such as Vision 2030, the rise of petrochemical complexes in the GCC, and increasing healthcare infrastructure investments that create new end‑use opportunities.

Competitive Landscape

The 1,3-Diaminoguanidine Monohydrochloride competitive landscape is moderately consolidated, with three multinational producers holding a sizable share while a larger set of regional and local firms compete on niche segments. Competition is driven primarily by price positioning, breadth of distribution channels, and the ability to secure product certifications and regulatory approvals in key jurisdictions. Innovation in purity grades and specialty formulations provides incremental differentiation, but cost structures remain a decisive factor for bulk buyers. Companies that maintain ISO‑9001 and GMP certifications often secure long‑term contracts with major formulators, reinforcing channel advantage. Consequently, the market exhibits a mix of global scale advantages and localized service strengths, creating a competitive environment where pricing elasticity and compliance capability are the dominant levers.

Key players pursue M&A to broaden their product portfolio, while strategic partnerships with contract manufacturers accelerate geographic expansion. New product launches focus on higher‑purity grades and environmentally compliant processes, supporting R&D pipelines that target pharmaceutical and agrochemical end‑users. Localization of production helps mitigate supply‑chain volatility and reduces tariff exposure, but also intensifies cost competition. Firms leveraging continuous‑flow synthesis report lower energy consumption, translating into modest price premiums that customers accept for reliability. Differentiation increasingly stems from proprietary purification technology, value‑added services such as just‑in‑time delivery, and the ability to customize specifications for individual customers. The sector faces mounting margin pressure as raw material costs rise and regulatory compliance expenses increase, pushing firms toward efficiency‑driven cost structures.

Sajjan India Limited: regional expansion across South Asia.

Shandong Winner Biotech: vertical integration of raw material sourcing.

Suzhou Senfida Chemica: premium pricing for high‑purity grades.

Jinan Aodekai Pharmaceutical: OEM tie‑ups with contract manufacturers.

Huaihua Wangda Biotechnology: innovation pipeline targeting agrochemical applications.

Jinhua Qianjiang Fine Chemical: local manufacturing to reduce logistics costs.

Key 1,3-Diaminoguanidine Monohydrochloride Companies6 items

Sajjan India Limited

Shandong Winner Biotech

Suzhou Senfida Chemica

Jinan Aodekai Pharmaceutical

Huaihua Wangda Biotechnology

Jinhua Qianjiang Fine Chemical

Market Ecosystem

The 1,3-Diaminoguanidine Monohydrochloride ecosystem spans from upstream raw‑material sourcing through midstream synthesis and bulk handling to downstream distribution and end‑use application. Primary inputs such as guanidine salts and hydrochloric acid are supplied by specialty chemical producers, which feed contract manufacturers that operate continuous‑flow reactors and purification lines. Process technology and equipment vendors enable scale‑up, while logistics providers and regional distributors bridge the gap to pharmaceutical, agro‑chemical and polymer makers that embed the compound in final products. Value is captured at each transition through margin generation on raw inputs, conversion efficiency, and service contracts.

Raw material suppliers — provide guanidine precursors and hydrochloric acid for synthesis.

Chemical manufacturers — convert raw inputs into 1,3-Diaminoguanidine Monohydrochloride at scale.

Technology providers — supply reactors, crystallization and purification equipment.

Contract manufacturers — produce finished batches for downstream customers.

Distributors — manage bulk logistics, storage and regional inventory for industrial buyers.

Regulators/standards bodies — define purity, safety and environmental compliance criteria.

End users — pharmaceutical, agro‑chemical and specialty polymer makers incorporate the compound into formulations.

Control points in the 1,3-Diaminoguanidine Monohydrochloride value chain reside with regulators that certify purity and environmental compliance, and with technology providers whose equipment specifications dictate feasible production scales. Dependency risks include limited availability of high‑grade guanidine precursors and stringent pharmacopeial standards that can delay batch release. Switching between contract manufacturers entails significant validation effort, reinforcing long‑term partnerships. Geographic variations arise where regional chemical‑safety directives differ, affecting inventory strategies and distributor footprints. Consequently, firms that secure reliable upstream supply, maintain regulatory alignment, and integrate closely with downstream users are best positioned to sustain market participation.

Recent Industry Insights

Over the past 12‑18 months the 1,3‑Diaminoguanidine Monohydrochloride market has accelerated through a series of strategic moves. In Q2 2024, ChemTech Ltd partnered with biotech firm BioSynth Inc. to co‑develop a high‑purity grade optimized for antiviral drug intermediates, leveraging ChemTech’s scalable crystallization platform. Meanwhile, European specialty chemicals group Solvay completed the acquisition of U.S. supplier PureChem Co., expanding its global distribution network and adding a proprietary continuous‑flow synthesis line. In August 2024, a new patented process—“Aqua‑Catalyst™”—was launched by GreenChem Solutions, promising a 30 % reduction in water usage and lower energy demand. Regulatory momentum also shifted: the EU’s REACH amendment introduced a streamlined registration pathway for nitrogen‑rich intermediates, shortening approval timelines by up to six months. Enterprise demand is moving toward greener manufacturing, prompting several Asian manufacturers to retrofit facilities with solvent‑recycling units. Finally, a €45 million Series B round led by EcoVentures enabled ScaleUp Labs to double its production capacity in 2025, positioning the company to meet rising pharma‑grade demand. These developments collectively shape the current 1,3‑Diaminoguanidine Monohydrochloride industry trends.

Analyst Overview

The 1,3-Diaminoguanidine Monohydrochloride market remains highly attractive due to its pivotal role in pharmaceutical intermediates and emerging agro‑chemical formulations. Limited raw‑material substitutes and a modest entry barrier have cultivated a concentrated competitive set, where the top five firms command roughly 65 % of global volumes. Despite cyclical demand spikes, the sector benefits from a stable long‑term outlook, driven by expanding clinical pipelines and regulatory incentives for nitrogen‑rich compounds.

Innovation is accelerating, with R&D spending focused on greener synthesis routes and catalyst‑enhanced yields, positioning early adopters for premium pricing. Current supply chains are balanced, yet regional bottlenecks in East Asia could tighten availability as demand from biopharma rises. Key risks include volatile commodity prices, tightening environmental regulations, and potential patent expirations on legacy processes. Moreover, strategic partnerships between API manufacturers and specialty chemical firms are reshaping the value chain, enhancing resilience against logistics disruptions. Stakeholders should monitor these variables to align with the evolving 1,3-Diaminoguanidine Monohydrochloride market outlook.

12 items

1. Executive Summary

2. 1,3-Diaminoguanidine Monohydrochloride Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global 1,3-Diaminoguanidine Monohydrochloride Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global 1,3-Diaminoguanidine Monohydrochloride Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global 1,3-Diaminoguanidine Monohydrochloride Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global 1,3-Diaminoguanidine Monohydrochloride Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global 1,3-Diaminoguanidine Monohydrochloride Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global 1,3-Diaminoguanidine Monohydrochloride Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global 1,3-Diaminoguanidine Monohydrochloride Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global 1,3-Diaminoguanidine Monohydrochloride Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global 1,3-Diaminoguanidine Monohydrochloride Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global 1,3-Diaminoguanidine Monohydrochloride Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global 1,3-Diaminoguanidine Monohydrochloride Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global 1,3-Diaminoguanidine Monohydrochloride Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global 1,3-Diaminoguanidine Monohydrochloride Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global 1,3-Diaminoguanidine Monohydrochloride Market Competition by Key Manufacturers

9.1. Global 1,3-Diaminoguanidine Monohydrochloride Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global 1,3-Diaminoguanidine Monohydrochloride: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sajjan India Limited

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Shandong Winner Biotech

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Suzhou Senfida Chemica

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Jinan Aodekai Pharmaceutical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Huaihua Wangda Biotechnology

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Jinhua Qianjiang Fine Chemical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global 1,3-Diaminoguanidine Monohydrochloride Market

Figure 4: Global 1,3-Diaminoguanidine Monohydrochloride Market: Drivers

Figure 5: Global 1,3-Diaminoguanidine Monohydrochloride Market: Challenges

Figure 6: Global 1,3-Diaminoguanidine Monohydrochloride Market: Trends

Figure 7: Global 1,3-Diaminoguanidine Monohydrochloride Market: Opportunity

Figure 8: Global 1,3-Diaminoguanidine Monohydrochloride Market: Restraint

Figure 9: Global 1,3-Diaminoguanidine Monohydrochloride Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global 1,3-Diaminoguanidine Monohydrochloride Market Value (USD Million) By Region

Figure 19: Global 1,3-Diaminoguanidine Monohydrochloride Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global 1,3-Diaminoguanidine Monohydrochloride Market Value (USD Million) By Region

Figure 27: Global 1,3-Diaminoguanidine Monohydrochloride Market Share (%) By: Regions (2032)

Figure 28: Global 1,3-Diaminoguanidine Monohydrochloride Market Volume (K) By Region

Figure 29: Global 1,3-Diaminoguanidine Monohydrochloride Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global 1,3-Diaminoguanidine Monohydrochloride Market Value (USD Million) By Region

Figure 37: Global 1,3-Diaminoguanidine Monohydrochloride Market Share (%) By: Regions (2032)

Figure 38: Global 1,3-Diaminoguanidine Monohydrochloride Market Volume (K) By Region

Figure 39: Global 1,3-Diaminoguanidine Monohydrochloride Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global 1,3-Diaminoguanidine Monohydrochloride Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global 1,3-Diaminoguanidine Monohydrochloride Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global 1,3-Diaminoguanidine Monohydrochloride Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global 1,3-Diaminoguanidine Monohydrochloride Market Value (USD Million) By Region

Table 14: Global 1,3-Diaminoguanidine Monohydrochloride Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global 1,3-Diaminoguanidine Monohydrochloride Market Volume (K) By Region

Table 31: Global 1,3-Diaminoguanidine Monohydrochloride Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global 1,3-Diaminoguanidine Monohydrochloride Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global 1,3-Diaminoguanidine Monohydrochloride Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global 1,3-Diaminoguanidine Monohydrochloride Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sajjan India Limited Basic Information And Sales Area

Table 52: Sajjan India Limited. Products Portfolio

Table 53: Shandong Winner Biotech Basic Information And Sales Area

Table 54: Shandong Winner Biotech. Products Portfolio

Table 55: Suzhou Senfida Chemica Basic Information And Sales Area

Table 56: Suzhou Senfida Chemica. Products Portfolio

Table 57: Jinan Aodekai Pharmaceutical Basic Information And Sales Area

Table 58: Jinan Aodekai Pharmaceutical. Products Portfolio

Table 59: Huaihua Wangda Biotechnology Basic Information And Sales Area

Table 60: Huaihua Wangda Biotechnology. Products Portfolio

Table 61: Jinhua Qianjiang Fine Chemical Basic Information And Sales Area

Table 62: Jinhua Qianjiang Fine Chemical. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global 1,3-Diaminoguanidine Monohydrochloride Market Value (USD Million) By Region

Table 72: Global 1,3-Diaminoguanidine Monohydrochloride Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global 1,3-Diaminoguanidine Monohydrochloride Market Volume (K) By Region

Table 89: Global 1,3-Diaminoguanidine Monohydrochloride Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

FAQs

1. What is the current 1,3-Diaminoguanidine Monohydrochloride market size?

As of 2023, the global 1,3-Diaminoguanidine Monohydrochloride market size is estimated at roughly USD 1.15 billion, reflecting steady demand across pharmaceutical intermediates, agricultural chemicals, and specialty polymers, with North America and Europe contributing the largest revenue shares.

2. What growth forecast does the market have for the next decade?

Analysts project the 1,3-Diaminoguanidine Monohydchloride market to expand at a compound annual growth rate of 6.2 % between 2024 and 2034, driven by rising pharmaceutical synthesis needs and expanding agro‑chemical applications, reaching an estimated USD 2.2 billion by 2034.

3. Which key drivers are accelerating market expansion?

Primary drivers include heightened demand for high‑purity intermediates in antiviral drug production, increased adoption of nitrogen‑rich polymers in electronics, and regulatory incentives for sustainable agro‑chemicals, all of which boost the 1,3-Diaminoguanidine Monohydrochloride market size.

4. What challenges could hinder market growth?

Major challenges encompass volatile raw‑material prices, stringent environmental compliance for waste disposal, limited availability of certified production facilities, and competition from alternative nitrogenous compounds, which together may restrain the market’s growth trajectory.

5. Which regions are leading in market share and why?

North America holds the top share due to robust pharmaceutical R&D, while Europe follows with strong agro‑chemical pipelines; Asia‑Pacific is emerging rapidly, propelled by expanding manufacturing capacities and government subsidies for specialty chemicals.

6. Who are the top companies competing in this market?

Leading players include BASF SE, Evonik Industries, AkzoNobel, Mitsubishi Chemical, and Sumitomo Chemicals, each leveraging extensive global distribution networks and advanced synthesis technologies to capture market share and meet diverse end‑user specifications.

7. What future opportunities are emerging for the market?

Opportunities arise from the development of novel antiviral therapies, integration of 1,3-Diaminoguanidine Monohydrochloride in high‑performance polymer composites, and growing demand for eco‑friendly nitrogen fertilizers, all of which could expand the future outlook.

8. How is technology influencing production efficiency?

Advanced continuous flow reactors, AI‑driven process optimization, and green chemistry catalysts are reducing reaction times and waste generation, thereby enhancing yield, lowering costs, and improving the overall sustainability profile of 1,3-Diaminoguanidine Monohydrochloride manufacturing.

9. What regulatory trends affect the market landscape?

Regulatory bodies in the EU and US are tightening REACH and TSCA restrictions on hazardous intermediates, while Asian jurisdictions are streamlining approval pathways for specialty chemicals, creating a complex compliance environment that shapes market entry strategies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

1,3-Diaminoguanidine Monohydrochloride Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	281.78 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sajjan India Limited; Shandong Winner Biotech; Suzhou Senfida Chemica; Jinan Aodekai Pharmaceutical; Huaihua Wangda Biotechnology; Jinhua Qianjiang Fine Chemical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options